[Click eStock] "CareLabs Forecasts Record Operating Profit of 7 Billion KRW This Year"

[Asia Economy Reporter Yoo Hyun-seok] Korea Investment & Securities announced on the 29th that CareLabs, which operates 'Goodoc,' the No.1 non-face-to-face medical service platform in Korea, is expected to achieve record-high performance growth this year. No investment opinion or target price was provided.

On the 29th, Taewan Oh, a researcher at Korea Investment & Securities, stated in a report that CareLabs is "expanding its business overseas" and "is expected to record sales of 78 billion KRW and operating profit of 7 billion KRW this year." These figures represent the highest level since the company's establishment. In the first quarter, CareLabs posted sales of 18.9 billion KRW and operating profit of 1.9 billion KRW, growing approximately 13.9% and 114.3% year-on-year, respectively.

Korea Investment & Securities expects that in the long term, the distribution of CareLabs' 'Goodoc' new business, the one-stop reception system, will expand, gradually increasing mobile and kiosk advertising as well as electronic prescription fees. Additionally, it analyzed that further growth momentum will be secured through the overseas expansion of the high operating margin beauty care platform Babitok into markets such as Thailand.

This content was produced with the assistance of AI translation services.